Samantha M Mucha, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 777 Kimole Ln, Suite 240, Adrian, MI 49221 Phone: 517-263-9491 Fax: 517-263-9591 |
Dr. Lascelles Pinnock, M.D Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 14575 Southfield Rd, Allen Park, MI 48101 Phone: 313-381-5170 Fax: 313-381-8790 |
Galen Donald Ohmart, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2079 S State Ave, Alpena, MI 49707 Phone: 989-354-2191 Fax: 989-356-0784 |
Jeffrey John Stanley, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 |
Dr. Erin Lynn Mckean, MD Otolaryngology - Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 |
Susan L Garetz, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1500 East Medical Center Dr, 2nd Floor Taubman Cter Recp G, Ann Arbor, MI 48109 Phone: 734-936-5730 |
Jeffrey Scott Moyer, MD Otolaryngology - Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 |
Amarbir Singh Gill, MD Otolaryngology - Plastic Surgery within the Head & Neck Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 |
Natalie S Justicz, Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 |
Dr. Robert Harris Gilman, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 24 Frank Lloyd Wright Dr, Ann Arbor, MI 48105 Phone: 734-998-6022 Fax: 734-998-9139 |
Mark E Prince, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 |
Chaz Luke Stucken, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 |
Terrence K Pleasant Jr., MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 |
Dr. Lawrence Kashat, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 380 Parkland Plz, Ann Arbor, MI 48103 Phone: 734-936-8051 |
Renee Michelle Banakis Hartl, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 349-364-0007 |
Dr. Jeffrey Tan Gu, MD Otolaryngology - Facial Plastic Surgery Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 |
Emily Zambricki Stucken, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 |
Robbi Ann Kupfer, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1500 E Medical Center Dr, Ann Arbor, MI 48109 Phone: 734-936-4000 |
Douglas B Chepeha, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 1500 East Medical Center Dr, 1st Floor Taubman Ctr Recp A, Ann Arbor, MI 48109 Phone: 734-936-8051 |
David Adam Zopf, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 1500 E Medical Center Dr, 2nd Floor Cs Mott Childrens Hospital Recp A, Ann Arbor, MI 48109 Phone: 734-936-5730 |
News Archive
Johns Hopkins researchers have developed a sugar-based molecular microcapsule that eliminates the toxicity of an anticancer agent developed a decade ago at Johns Hopkins, called 3-bromopyruvate, or 3BrPA, in studies of mice with implants of human pancreatic cancer tissue. The encapsulated drug packed a potent anticancer punch, stopping the progression of tumors in the mice, but without the usual toxic effects.
Stroke risk increased significantly in the days, weeks and months after shingles appeared, despite use of the shingles vaccine and antiviral therapy to treat it, according to preliminary research to be presented in Honolulu at the American Stroke Association's International Stroke Conference 2019, a world premier meeting for researchers and clinicians dedicated to the science and treatment of cerebrovascular disease.
Despite the mounting death toll of America's opioid crisis, only a minority of facilities that treat substance use disorders offer patients buprenorphine, naltrexone or methadone-the three FDA-approved medications for the long-term management of opioid use disorder, according to a new study from researchers at the Johns Hopkins Bloomberg School of Public Health.
A new synthetic Petri dish coating could overcome a major challenge to the advancement of human embryonic stem cell research, say University of Michigan researchers.
GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today provided an update on its vaccine trials progress.
› Verified 1 days ago